Gilead Sciences, Inc. (NASDAQ:GILD)

Stock Price: $62.63
+0.29 (0.46%)
Updated Sep 27, 2022 08:00 PM GMT+0000
Featured app
eToro review
Invest now
68% of retail CFD accounts lose money
Overview
Financials
Statistics
Profile
Chart
Market Cap 78.50B
Revenue 27.52B
Gross Profit 20.80B
Shares Out 1.25B
EPS (ttm) 3.28
PE Ratio 18.8869
Forward PE 9.3823
Dividend Rate (ttm) 2.8494
Dividend Yield 0.0457
Trading Day Sep 27
Last Price $62.63
Previous Close $62.34
Change ($) 0.29
Change (%) 0.46%
Day's Open 62.43
Day's Range 62.28 - 63.52
Day's Volume 7.13M
52 Week Range 55.27 - 71.47

About Gilead Sciences, Inc.

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer.

Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California. Gilead has promoted equity, particularly healthcare equity, since the company brought its first therapies to the market. Through global partnerships, Gilead's medicines today reach millions of people in low- and middle-income countries around the world.

In the United States, Gilead has committed more than $100 million over 10 years through the COMPASS Initiative to community organizations that are working to combat HIV in the Southern United States. In 2020, Gilead launched the Racial Equity Community Impact Fund to support organizations tackling racial inequities affecting Black communities across the United States.

NASDAQ:GILD stock is currently trading at $62.63 as of 08:00 PM UTC, Sep 27, 2022. Use the financials tab to find out more about Gilead Sciences, Inc.'s key financial metrics and recent earnings reports, or track its share price in real time on the chart tab. If you would like to buy shares in Gilead Sciences, Inc., our detailed guide explains how to buy Gilead Sciences, Inc. stock.

News

Quick info

Country
United States
Industry
Biological Product (except Diagnostic) Manufacturing
Sector
Manufacturing
Employees
13,600
CEO
Daniel O'Day
Address
333 Lakeside Dr
Foster City
California
94404-1147
Phone
16505743000
Website
www.gilead.com
Ticker Symbol
GILD
Reporting Currency
USD